Latest News

Annual Stockholders Meeting

Date: August 9, 2022 | READ MORE >

Annual Stockholders Meeting

Date: August 9, 2022 | READ MORE >

Ampio Letter to Stockholders

Date: August 3, 2022 | READ MORE >

Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders

Date: June 2, 2022 | READ MORE >

Ampio Pharmaceuticals Reports First-Quarter Financial Results

Date: May 17, 2022 | READ MORE >

Ampio Independent Committee to Conduct Investigation

Date: May 17, 2022 | READ MORE >

Ampio Pharmaceuticals, Inc. to Hold Conference Call

Date: April 27, 2022 | READ MORE >

AMPIO PROVIDES REGULATORY UPDATE

Date: April 21, 2022 | READ MORE >

Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights

Date: March 30, 2022 | READ MORE >

Ampio Pharmaceuticals, Inc. to Hold Fourth Quarter 2021 Earnings and Business Update Call

Date: March 23, 2022 | READ MORE >

Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference

Date: March 9, 2022 | READ MORE >

Video from March 2nd Conference and Webinar Available

Date: March 3, 2022 | READ MORE >

Ampio Pharmaceuticals, Inc. Releases Positive Phase 3 Data Analysis for Ampion™ Targeting Severe Osteoarthritis of the Knee (OAK)

Date: March 2, 2022 | READ MORE >

Ampio Pharmaceuticals, Inc. to Host a Conference Call and Webinar

Date: March 2, 2022 | READ MORE >

Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes

Date: February 10, 2022 | READ MORE >

Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference

Date: January 6, 2022 | READ MORE >

Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders

Date: December 16, 2021 | READ MORE >

AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING

Date: December 13, 2021 | READ MORE >

Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1

Date: November 29, 2021 | READ MORE >

Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO & Chairman, Michael Martino

Date: November 23, 2021 | READ MORE >